drugset / Trial / NCT02171390

Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy

NCT02171390

Phase 4 Completed 130 enrolled Gulhane School of Medicine
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study searched for answers to two questions 1. Is there endothelial dysfunction, inflammation and insulin resistance in patients with congenital hypogonadotropic hypogonadism? 2. What is the effect of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resistance?

Timeline

Start
2008-08
Primary completion
2012-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule 50 mg Intramuscular
Comparator Testosterone Small molecule 250 mg Intramuscular